While the use of cannabis extracts instead of raw plant material reduces many risks associated with smoking, cannabis concentrates may pose different health hazards if they are not free of the organic, or “residual” solvents used in the extraction process. Residual solvents remaining in cannabis products may potentially cause adverse health effects including cancer, reproductive harm, and damage to the nervous system, lungs, kidneys, and liver.
Therefore, many states require testing of cannabis concentrate products for residual solvent levels to ensure safe consumption. US Cannalytics is dedicated to ensuring the safety of medical and legal adult-use cannabis extracts by using advanced gas chromatography-mass spectrometry (GC-MS) instrumentation with ISO / IEC 17025:2017 accredited methodology to accurately quantify residual solvents in the parts per million (ppm) range.
